- Home
- Publications
- Publication Search
- Publication Details
Title
Workshop Report
Authors
Keywords
-
Journal
CIRCULATION RESEARCH
Volume 125, Issue 9, Pages 855-867
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2019-10-11
DOI
10.1161/circresaha.119.315378
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Emerging Role of Organ‐on‐a‐Chip Technologies in Quantitative Clinical Pharmacology Evaluation
- (2019) Nina Isoherranen et al. CTS-Clinical and Translational Science
- Human Induced Pluripotent Stem Cell Model of Trastuzumab-Induced Cardiac Dysfunction in Breast Cancer Patients
- (2019) Tomoya Kitani et al. CIRCULATION
- A Platform for Generation of Chamber-Specific Cardiac Tissues and Disease Modeling
- (2019) Yimu Zhao et al. CELL
- Dissecting hiPSC-CM pacemaker function in a cardiac organoid model
- (2019) Mirja L. Schulze et al. BIOMATERIALS
- A Physiological Biomimetic Culture System for Pig and Human Heart Slices
- (2019) Qinghui Ou et al. CIRCULATION RESEARCH
- Modelling diastolic dysfunction in induced pluripotent stem cell-derived cardiomyocytes from hypertrophic cardiomyopathy patients
- (2019) Haodi Wu et al. EUROPEAN HEART JOURNAL
- Advanced in vitro models of vascular biology: Human induced pluripotent stem cells and organ-on-chip technology
- (2018) Amy Cochrane et al. ADVANCED DRUG DELIVERY REVIEWS
- Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cells to Assess Drug Cardiotoxicity: Opportunities and Problems
- (2018) Tarek Magdy et al. Annual Review of Pharmacology and Toxicology
- Generation and primary characterization of iAM-1, a versatile new line of conditionally immortalized atrial myocytes with preserved cardiomyogenic differentiation capacity
- (2018) Jia Liu et al. CARDIOVASCULAR RESEARCH
- Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity
- (2018) Xi Yang et al. JOURNAL OF APPLIED TOXICOLOGY
- Genome Editing of Induced Pluripotent Stem Cells to Decipher Cardiac Channelopathy Variant
- (2018) Priyanka Garg et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cross-Site Reliability of Human Induced Pluripotent stem cell-derived Cardiomyocyte Based Safety Assays Using Microelectrode Arrays: Results from a Blinded CiPA Pilot Study
- (2018) Daniel Millard et al. TOXICOLOGICAL SCIENCES
- Response of human induced pluripotent stem cell-derived cardiomyocytes to several pharmacological agents when intrinsic syncytial pacing is overcome by acute external stimulation
- (2018) Haoyu Zeng et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Action Potential Recording and Pro-arrhythmia Risk Analysis in Human Ventricular Trabeculae
- (2018) Yusheng Qu et al. Frontiers in Physiology
- International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment
- (2018) Ksenia Blinova et al. Cell Reports
- Thorough QT/QTc in a Dish: An In Vitro Human Model That Accurately Predicts Clinical Concentration-QTc Relationships
- (2018) Alexander D. Blanchette et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Frequency-Dependent Multi-Well Cardiotoxicity Screening Enabled by Optogenetic Stimulation
- (2017) Susanne Rehnelt et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells
- (2017) Arun Sharma et al. Science Translational Medicine
- Deconvoluting Kinase Inhibitor Induced Cardiotoxicity
- (2017) Sarah D. Lamore et al. TOXICOLOGICAL SCIENCES
- An impedance-based approach using human iPSC-derived cardiomyocytes significantly improves in vitro prediction of in vivo cardiotox liabilities
- (2017) Bryan Koci et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Current nonclinical testing paradigm enables safe entry to First-In-Human clinical trials: The IQ consortium nonclinical to clinical translational database
- (2017) Thomas M. Monticello et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Identification of potent tricyclic prodrug S1P1 receptor modulators
- (2017) David Marcoux et al. MedChemComm
- Erratum: Corrigendum: Functional Coupling of Human Microphysiology Systems: Intestine, Liver, Kidney Proximal Tubule, Blood-Brain Barrier and Skeletal Muscle
- (2017) Lawrence Vernetti et al. Scientific Reports
- A new paradigm for drug-induced torsadogenic risk assessment using human iPS cell-derived cardiomyocytes
- (2017) Hiroyuki Ando et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Modeling susceptibility to drug-induced long QT with a panel of subject-specific induced pluripotent stem cells
- (2017) Francesca Stillitano et al. eLife
- Adult Human Primary Cardiomyocyte-Based Model for the Simultaneous Prediction of Drug-Induced Inotropic and Pro-arrhythmia Risk
- (2017) Nathalie Nguyen et al. Frontiers in Physiology
- Quantitative Comparison of Effects of Dofetilide, Sotalol, Quinidine, and Verapamil between Human Ex vivo Trabeculae and In silico Ventricular Models Incorporating Inter-Individual Action Potential Variability
- (2017) Oliver J. Britton et al. Frontiers in Physiology
- MUSCLEMOTION
- (2017) Luca Sala et al. CIRCULATION RESEARCH
- Cardiac spheroids as promising in vitro models to study the human heart microenvironment
- (2017) Liudmila Polonchuk et al. Scientific Reports
- IK1-enhanced human-induced pluripotent stem cell-derived cardiomyocytes: an improved cardiomyocyte model to investigate inherited arrhythmia syndromes
- (2016) Ravi Vaidyanathan et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform
- (2016) Chris Denning et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Assessment of the clinical cardiac drug-drug interaction associated with the combination of hepatitis C virus nucleotide inhibitors and amiodarone in guinea pigs and rhesus monkeys
- (2016) Christopher P. Regan et al. HEPATOLOGY
- Human induced pluripotent stem cell–derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity
- (2016) Paul W Burridge et al. NATURE MEDICINE
- Interaction between amiodarone and hepatitis-C virus nucleotide inhibitors in human induced pluripotent stem cell-derived cardiomyocytes and HEK-293 Cav 1.2 over-expressing cells
- (2016) Armando Lagrutta et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Identification and Preclinical Pharmacology of BMS-986104: A Differentiated S1P1 Receptor Modulator in Clinical Trials
- (2016) T. G. Murali Dhar et al. ACS Medicinal Chemistry Letters
- Human ex-vivo action potential model for pro-arrhythmia risk assessment
- (2016) Guy Page et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- The Comprehensive in Vitro Proarrhythmia Assay (CiPA) initiative — Update on progress
- (2016) Thomas Colatsky et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Matrigel Mattress: A Method for the Generation of Single Contracting Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
- (2015) Tromondae K Feaster et al. CIRCULATION RESEARCH
- Interaction Between Amiodarone and Sofosbuvir-based Treatment for Hepatitis C Virus Infection: Potential Mechanisms and Lessons to be Learned
- (2015) David J. Back et al. GASTROENTEROLOGY
- Extreme Bradycardia After First Doses of Sofosbuvir and Daclatasvir in Patients Receiving Amiodarone: 2 Cases Including a Rechallenge
- (2015) Sophie Renet et al. GASTROENTEROLOGY
- An analysis of the attrition of drug candidates from four major pharmaceutical companies
- (2015) Michael J. Waring et al. NATURE REVIEWS DRUG DISCOVERY
- The Concordance between Nonclinical and Phase I Clinical Cardiovascular Assessment from a Cross-Company Data Sharing Initiative
- (2014) Lorna Ewart et al. TOXICOLOGICAL SCIENCES
- Developmental cues for the maturation of metabolic, electrophysiological and calcium handling properties of human pluripotent stem cell-derived cardiomyocytes
- (2014) Wendy Keung et al. Stem Cell Research & Therapy
- Physical developmental cues for the maturation of human pluripotent stem cell-derived cardiomyocytes
- (2014) Renjun Zhu et al. Stem Cell Research & Therapy
- Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
- (2014) Raffaele Coppini et al. Jove-Journal of Visualized Experiments
- Rechanneling the cardiac proarrhythmia safety paradigm: A meeting report from the Cardiac Safety Research Consortium
- (2013) Philip T. Sager et al. AMERICAN HEART JOURNAL
- Mechanism-Based Facilitated Maturation of Human Pluripotent Stem Cell–Derived Cardiomyocytes
- (2013) Deborah K. Lieu et al. Circulation-Arrhythmia and Electrophysiology
- Preservation of cardiomyocytes from the adult heart
- (2013) Najah Abi-Gerges et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Structural and Functional Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells
- (2013) Scott D. Lundy et al. STEM CELLS AND DEVELOPMENT
- Assessment of beating parameters in human induced pluripotent stem cells enables quantitative in vitro screening for cardiotoxicity
- (2013) Oksana Sirenko et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells
- (2012) Christopher Rao et al. BIOMATERIALS
- The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate
- (2012) P Gergely et al. BRITISH JOURNAL OF PHARMACOLOGY
- Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics
- (2012) Cecile Terrenoire et al. JOURNAL OF GENERAL PHYSIOLOGY
- Pharmacological effects of CS-0777, a selective sphingosine 1-phosphate receptor-1 modulator: Results from a 12-week, open-label pilot study in multiple sclerosis patients
- (2012) James B. Moberly et al. JOURNAL OF NEUROIMMUNOLOGY
- Characterization of Human-Induced Pluripotent Stem Cell–Derived Cardiomyocytes: Bioenergetics and Utilization in Safety Screening
- (2012) Payal Rana et al. TOXICOLOGICAL SCIENCES
- Estimating the Risk of Drug-Induced Proarrhythmia Using Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes
- (2011) Liang Guo et al. TOXICOLOGICAL SCIENCES
- Use of human stem cell derived cardiomyocytes to examine sunitinib mediated cardiotoxicity and electrophysiological alterations
- (2011) J.D. Cohen et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Development of a Drug Screening Platform Based on Engineered Heart Tissue
- (2010) Arne Hansen et al. CIRCULATION RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started